Skip to main content
. 2020 May 23;27(6):1072–1081. doi: 10.1007/s12282-020-01111-1

Fig. 5.

Fig. 5

SNORA71B promotes breast cancer cell epithelial-mesenchymal transition and across blood–brain barrier. a, b Western blot assay was exploited to analyze the effect of SNORA71B on EMT progress in SNORA71B-transfected low BM BC cells (MDA-MB-231). c, d Transwell invasion assay using the in vitro BBB model detected the effect of SNORA71B on high BM BC cells (MDA-MB-231BM) across the BBB. The results were presented as the means ± SDs (n = 3). *P < 0.05, **P < 0.01